Product class:
|
Medicinal product with marketing authorization
|
Medicinal product class:
|
Veterinary medicine
|
Name of medicinal product:
|
Enzaprost
|
Active substances:
|
|
ATC code:
|
QG02AD01
|
Dosage form:
|
solution for injection
|
Strength:
|
5mg 1ml
|
Legal status for supply*:
|
Subject to medicinal prescription
|
Summary of product characteristics (SPC):
|
(last updated December 23, 2020)
|
Package information leaflet (PIL):
|
EST (last updated December 23, 2020)
|
Labelling:
|
(last updated December 23, 2020)
|
Indication:
|
|
Safety features:
|
No
|
Marketing authorization holder:
|
Ceva Sante Animale
|
Marketing authorization number:
|
1728
|
Marketing authorization issued on:
|
July 13, 2012
|
Marketing authorization expires on:
|
Unlimited
|
Marketing authorization procedure type:
|
Mutual recognition
|
Assessment report:
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
1557930
|
Enzaprost
|
solution for injection
|
5mg 1ml 5ml 10TK
|
Prescription
|
|
|
05.12.2016
|
|
|
1557941
|
Enzaprost
|
solution for injection
|
5mg 1ml 10ml 5TK
|
Prescription
|
|
|
|
|
|
1557952
|
Enzaprost
|
solution for injection
|
5mg 1ml 30ml 1TK
|
Prescription
|
|
|
16.10.2017
|
|
|
1557963
|
Enzaprost
|
solution for injection
|
5mg 1ml 50ml 1TK
|
Prescription
|
|
|
07.11.2023
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere